Suspected Interstitial Lung Disease in COPDGene Study

Authors

Jonathan A Rose
Aravind A Menon
Takuya Hino
Akinori Hata
Mizuki Nishino
David A Lynch
Ivan O Rosas
Souheil El-Chemaly
Benjamin A Raby
Samuel Y Ash
Bina Choi
George R Washko
Edwin K Silverman
Michael H Cho
Hiroto Hatabu
Rachel K Putman
Gary M Hunninghake

Publication Date

1-1-2023

Journal

American Journal of Respiratory and Critical Care Medicine

DOI

10.1164/rccm.202203-0550OC

PMID

35930450

PMCID

PMC9952869

PubMedCentral® Posted Date

8-5-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Humans, Lung, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Smoking, Oxygen, interstitial lung disease, interstitial lung abnormalities, pulmonary fibrosis

Abstract

Rationale

Although interstitial lung abnormalities (ILA), specific patterns of incidentally-detected abnormal density on computed tomography, have been associated with abnormal lung function and increased mortality, it is unclear if a subset with incidental interstitial lung disease (ILD) accounts for these adverse consequences.

Objectives

To define the prevalence and risk factors of suspected ILD and assess outcomes.

Methods

Suspected ILD was evaluated in the COPDGene (Chronic Obstructive Pulmonary Disease Genetic Epidemiology) study, defined as ILA and at least one additional criterion: definite fibrosis on computed tomography, FVC less than 80% predicted, or DL_CO less than 70% predicted. Multivariable linear, longitudinal, and Cox proportional hazards regression models were used to assess associations with St. George's Respiratory Questionnaire, 6-minute-walk test, supplemental oxygen use, respiratory exacerbations, and mortality.

Measurements and Main Results

Of 4,361 participants with available data, 239 (5%) had evidence for suspected ILD, whereas 204 (5%) had ILA without suspected ILD. In multivariable analyses, suspected ILD was associated with increased St. George's Respiratory Questionnaire score (mean difference [MD], 3.9 points; 95% confidence interval [CI], 0.6–7.1; P = 0.02), reduced 6-minute-walk test (MD, −35 m; 95% CI, −56 m to −13 m; P = 0.002), greater supplemental oxygen use (odds ratio [OR], 2.3; 95% CI, 1.1–5.1; P = 0.03) and severe respiratory exacerbations (OR, 2.9; 95% CI, 1.1–7.5; P = 0.03), and higher mortality (hazard ratio, 2.4; 95% CI, 1.2–4.6; P = 0.01) compared with ILA without suspected ILD. Risk factors associated with suspected ILD included self-identified Black race (OR, 2.0; 95% CI, 1.1–3.3; P = 0.01) and pack-years smoking history (OR, 1.2; 95% CI, 1.1–1.3; P = 0.0005).

Conclusions

Suspected ILD is present in half of those with ILA in COPDGene and is associated with exercise decrements and increased symptoms, supplemental oxygen use, severe respiratory exacerbations, and mortality.